Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S

Address
Via Operai 40

Sponsor Overview

assignment
2
sponsored trials
science
15
molecules
location_city
24
research centres
public
1
country
person_search
25
investigators

Specializations

Multiple Sclerosis and Neuroinflammatory Disease

Clinical research is concentrated on relapsing-remitting multiple sclerosis, with attention to disease activity, lesion burden, and long-term control of inflammatory progression.

  • Multiple sclerosis disease activity
  • Relapsing-remitting multiple sclerosis
  • Magnetic resonance imaging lesion monitoring

Interest extends to outcomes linked with sustained absence of clinical and radiological activity, including NEDA-3 as a key therapeutic endpoint.

Radiologically Isolated Syndrome

Research activity also includes radiologically isolated syndrome, focusing on early identification of individuals at risk of developing symptomatic demyelinating disease.

  • Radiologically isolated syndrome
  • Early demyelinating disease
  • MRI-based risk assessment

Therapeutic interest in this area centers on imaging markers of new inflammatory activity and the transition from incidental findings to clinically manifest disease.

Autologous Haematopoietic Stem Cell Transplantation

The sponsor supports research in aggressive multiple sclerosis involving autologous haematopoietic stem cell transplantation as a treatment strategy for difficult-to-control disease.

  • Autologous haematopoietic stem cell transplantation
  • Aggressive multiple sclerosis
  • Disease remission

Relevant outcomes include sustained suppression of disease activity and achievement of no evidence of disease activity over extended follow-up.

Immunomodulation and Vaccine-Based Approaches

Another area of interest is immunomodulatory therapy, including vaccine-based strategies explored in relation to early multiple sclerosis risk and immune response modulation.

  • Immunomodulation
  • Vaccine-based therapy
  • Immune response modulation

This reflects a focus on interventions that may influence inflammatory pathways and alter the course of central nervous system autoimmunity.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 15 total (7% not shared with other sponsors)

This sponsor works with 15 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
13%
Return partnership rate
3 of 24 sites collaborated multiple times

This sponsor has worked with 24 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nervous System Diseases2 trials
    449 other sponsors

Partnered Research Centres

24 centres
location_city
assignment47
ARNAS Civico Di Cristina Benfratelli
Address
Piazza Nicola Leotta 4, 90127 Palermo
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment226
Azienda Ospedaliera Universitaria Senese
Address
Strada Delle Scotte 14, 53100 Siena
Learn morearrow_forward
location_city
assignment283
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Address
Piazza Luigi Miraglia 2, 80138 Naples
Learn morearrow_forward
location_city
assignment624
Azienda Ospedaliero Universitaria Careggi
Address
Largo Giovanni Alessandro Brambilla 3, 50134 Florence
Learn morearrow_forward
location_city
assignment66
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari
Address
Piazzale Giulio Cesare 11, 70124 Bari
Learn morearrow_forward
Page 1 of 4

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.